Detalles de la búsqueda
1.
Diagnostic performance of [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma.
Eur Radiol
; 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38625612
2.
Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET.
Am J Med Genet A
; 185(4): 1282-1287, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33615670
3.
Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid gland.
Lancet Oncol
; 21(11): e528-e537, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152312
4.
Endocrine-Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management.
Oncologist
; 25(4): 290-300, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32297436
5.
Update on the Treatment of Medullary Thyroid Carcinoma in Patients with Multiple Endocrine Neoplasia Type 2.
Horm Metab Res
; 52(8): 588-597, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32299110
6.
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.
Curr Treat Options Oncol
; 21(11): 85, 2020 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32862332
7.
Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer.
Oncologist
; 24(1): 16-e14, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30297385
8.
Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia.
N Engl J Med
; 383(14): 1387-1389, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32905668
9.
Response of adrenocortical carcinoma liver metastases to hepatic artery infusion floxuridine.
HPB (Oxford)
; 25(11): 1446-1449, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37453816
10.
PARP Inhibitors: The Cornerstone of DNA Repair-Targeted Therapies.
Oncology (Williston Park)
; 31(4): 265-73, 2017 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28412778
11.
12.
The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study.
BMC Cancer
; 14: 523, 2014 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25048685
13.
Managing Catecholamine Release Syndrome During and Following Lu-177-DOTATATE in High-Risk Pheochromocytoma Patients.
JCEM Case Rep
; 2(4): luae049, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601063
14.
Pulmonary Metastasectomy for Adrenocortical Carcinoma-Not If, but When.
Cancers (Basel)
; 16(4)2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38398093
15.
Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts.
Cancer Res Commun
; 4(3): 834-848, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451783
16.
International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects.
Eur J Endocrinol
; 190(4): G15-G24, 2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552173
17.
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.
Nat Rev Endocrinol
; 20(3): 168-184, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38097671
18.
Grade Progression and Intrapatient Tumor Heterogeneity as Potential Contributors to Resistance in Gastroenteropancreatic Neuroendocrine Tumors.
Cancers (Basel)
; 15(14)2023 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509373
19.
Pulmonary large cell neuroendocrine carcinoma (LCNEC): a population-based study addressing recent molecular-genetic advances and emerging therapeutic approaches.
Clin Exp Med
; 23(7): 3947-3955, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37060529
20.
Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care.
Endocr Relat Cancer
; 30(7)2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37017232